NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Joint Stock Company Kaspi.kz (“Kaspi” or the “Company”) (NASDAQ:KSPI) on behalf of Kaspi stockholders. Our investigation concerns whether Kaspi has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On September 19, 2024, Culper Research published a report alleging, among other things, that Kaspi “systematically misled U.S. investors and regulators in its repeated claims-especially ahead of the Company’s January 2024 NASDAQ listing-that the Company has zero exposure to Russia,” when in fact “Russia has contributed materially to Kaspi’s reported growth.” Following publication of the Culper Research report, Kaspi’s American Depositary Receipt (“ADR”) price fell $19.20 per ADR, or 16.13%, to close at $99.81 per ADR on September 19, 2024.
If you purchased or otherwise acquired Kaspi shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com
- MRNA DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA - October 6, 2024
- NNE DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NANO Nuclear Energy, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – NNE - October 6, 2024
- ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Bumble Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BMBL - October 6, 2024